LeMaitre Vascular - 19 Year Stock Price History | LMAT

Historical daily share price chart and data for LeMaitre Vascular since 2006 adjusted for splits and dividends. The latest closing stock price for LeMaitre Vascular as of April 24, 2025 is 91.76.
  • The all-time high LeMaitre Vascular stock closing price was 107.70 on November 22, 2024.
  • The LeMaitre Vascular 52-week high stock price is 109.58, which is 19.4% above the current share price.
  • The LeMaitre Vascular 52-week low stock price is 64.44, which is 29.8% below the current share price.
  • The average LeMaitre Vascular stock price for the last 52 weeks is 88.92.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
LeMaitre Vascular Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 90.9211 91.2456 103.7450 77.8900 91.7600 -0.17%
2024 79.2683 56.1217 107.7050 53.4398 91.9139 63.63%
2023 54.4513 44.5028 67.1555 43.8171 56.1712 24.60%
2022 45.4023 49.9163 54.5657 37.9470 45.0807 -7.40%
2021 50.2470 38.6183 61.1342 38.6183 48.6853 25.10%
2020 29.3394 33.9670 39.6561 20.0200 38.9162 14.09%
2019 28.5825 21.9481 34.3560 21.0661 34.1093 53.77%
2018 31.1783 28.9583 38.2432 20.6532 22.1827 -25.13%
2017 27.9986 23.3058 36.3536 20.2298 29.6283 26.58%
2016 15.9460 14.4594 23.5183 11.4250 23.4075 48.46%
2015 10.2631 7.0436 16.2417 6.5663 15.7665 128.82%
2014 6.7820 7.0750 7.4850 5.9155 6.8905 -2.73%
2013 5.9127 5.0052 7.6233 5.0052 7.0838 42.02%
2012 5.0832 4.9034 5.6483 4.2908 4.9879 -1.37%
2011 5.6166 5.8555 6.3649 4.5105 5.0572 -11.46%
2010 4.8472 4.2018 6.1423 3.7293 5.7120 35.40%
2009 2.7835 1.8056 4.2186 1.6115 4.2186 116.64%
2008 3.0305 5.0624 5.6614 1.5693 1.9473 -62.77%
2007 5.4664 5.1045 6.4545 4.6911 5.2311 3.33%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.946B $0.220B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $227.162B 27.40
Boston Scientific (BSX) United States $140.689B 37.90
Stryker (SYK) United States $132.255B 28.42
EssilorLuxottica (ESLOY) France $128.431B 0.00
Medtronic (MDT) Ireland $105.938B 15.47
Lonza Group Ag (LZAGY) Switzerland $47.424B 0.00
Haleon (HLN) United Kingdom $46.151B 26.20
ResMed (RMD) United States $31.269B 24.08
Agilent Technologies (A) United States $29.217B 19.30
GE HealthCare Technologies (GEHC) United States $28.556B 13.89
Terumo (TRUMY) Japan $28.160B 0.00
Koninklijke Philips (PHG) Netherlands $22.192B 15.85
Zimmer Biomet Holdings (ZBH) United States $19.373B 12.24
Insulet (PODD) United States $17.332B 74.11
Baxter (BAX) United States $14.818B 10.66
Smith & Nephew SNATS (SNN) United Kingdom $11.356B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Lantheus Holdings (LNTH) United States $6.938B 17.06
Bio-Rad Laboratories (BIO) United States $6.672B 23.10
Demant (WILYY) Denmark $6.644B 0.00
Prestige Consumer Healthcare (PBH) United States $3.977B 18.98
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.455B 9.89
ICU Medical (ICUI) United States $3.400B 29.07
Haemonetics (HAE) United States $2.872B 13.52
Envista Holdings (NVST) United States $2.614B 20.80
GN Store Nord (GNNDY) Denmark $2.188B 14.75
QuidelOrtho (QDEL) United States $1.698B 14.22
AtriCure (ATRC) United States $1.565B 0.00
Kestra Medical Technologies (KMTS) United States $1.214B 0.00
Green Thumb Industries (GTBIF) United States $1.189B 18.67
AdaptHealth (AHCO) United States $1.051B 10.12
BioLife Solutions (BLFS) United States $1.041B 0.00
InMode (INMD) Israel $1.038B 8.67
Neogen (NEOG) United States $0.953B 12.19
Phibro Animal Health (PAHC) United States $0.700B 10.74
Evolus (EOLS) United States $0.686B 0.00
Curaleaf Holdings (CURLF) Canada $0.649B 0.00
Valneva SE (VALN) France $0.552B 0.00
Owens & Minor (OMI) United States $0.535B 4.56
CeriBell (CBLL) United States $0.532B 0.00
Capricor Therapeutics (CAPR) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.450B 0.00
Surmodics (SRDX) United States $0.394B 0.00
Omeros (OMER) United States $0.394B 0.00
SNDL (SNDL) Canada $0.368B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Cresco Labs (CRLBF) United States $0.328B 0.00
VAREX IMAGING (VREX) United States $0.302B 13.07
Viemed Healthcare (VMD) United States $0.262B 23.68
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 15.65
Sanuwave Health (SNWV) United States $0.256B 0.00
Verano Holdings (VRNOF) United States $0.251B 0.00
Aurora Cannabis (ACB) Canada $0.250B 44.40
Cerus (CERS) United States $0.242B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Quanterix (QTRX) United States $0.200B 0.00
Canopy Growth (CGC) Canada $0.189B 0.00
High Tide (HITI) Canada $0.187B 0.00
Biote (BTMD) United States $0.181B 4.12
TriSalus Life Sciences (TLSI) United States $0.175B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.24
Brainsway (BWAY) Israel $0.155B 48.47
Jin Medical (ZJYL) China $0.147B 0.00
Organigram Global (OGI) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.123B 15.42
Agape ATP (ATPC) $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
TerrAscend (TSNDF) Canada $0.083B 0.00
Exagen (XGN) United States $0.080B 0.00
MacroGenics (MGNX) United States $0.079B 0.00
Veru (VERU) United States $0.078B 0.00
Fonar (FONR) United States $0.076B 10.65
Zynex (ZYXI) United States $0.066B 24.22
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.063B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
United-Guardian (UG) United States $0.038B 11.61
Apyx Medical (APYX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.036B 0.00
Rockwell Medical (RMTI) United States $0.035B 51.50
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.010B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00